Inhibition of p53-mediated transcriptional responses by mithramycin A

Oncogene

Volumn 23, Issue 57, 2004, Pages 9190-9200

  Koutsodontis, George ^a   Kardassis, Dimitris ^a,b  

^a UNIVERSITY OF CRETE   (Greece)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

5 fluorouracil; Genotoxic stress; Mithramycin A; p21Cip1; p53; PUMA; Sp1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; FLUOROURACIL; MITHRAMYCIN; PROTEIN BAK; PROTEIN P53; TRANSCRIPTION FACTOR SP1;

APOPTOSIS; ARTICLE; BIOTINYLATION; CELL STRAIN HEPG2; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PAGET BONE DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA PRIMERS; HUMANS; LIVER NEOPLASMS; PLICAMYCIN; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 11244325724     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208141     Document Type: Article

References (47)

1. Aich P and Dasgupta D. (1995). Biochemistry, 34, 1376-1385.
2. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA and Miller DM. (1991). J. Clin. Invest., 88, 1613-1621.
3. Brown JH and Kennedy BJ. (1965). N. Engl. J. Med., 272, 111-118.
4. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts M and Sherr CJ. (1999). EMBO J., 18, 1571-1583.
5. Choi J and Donehower LA. (1999). Cell Mol. Life Sci., 55, 38-47.
6. de Boer E, Rodriguez P, Bonte E, Krijgsveld J, Katsantoni E, Heck A, Grosveld F and Strouboulis J. (2003). Proc. Natl. Acad. Sci. USA, 100, 7480-7485.
7. de Siervi A, Marinissen M, Diggs J, Wang XF, Pages G and Senderowicz A. (2004). Cancer Res., 64, 743-750.
8. Dotto GP. (2000). Biochim. Biophys. Acta, 1471, M43-M56.
9. Elias EG and Evans JT. (1972). J. Bone Joint Surg., 54-A, 1730-1736.
10. Gartel AL and Tyner AL. (2002). Mol. Cancer Ther., 1, 639-649.
11. Hall PA, Campbell SJ, O'neill M, Royston DJ, Nylander K, Carey FA and Kernohan NM. (2000). Carcinogenesis, 21, 153-160.
12. Hall TJ, Schaeublin M and Chambers TJ. (1993). Biochem. Biophys. Res. Commun., 195, 1245-1253.
13. Harper JW and Elledge SJ. (1996). Curr. Opin. Genet. Dev., 6, 56-64.
14. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP and Wei N. (1995). Mol. Biol. Cell, 6, 387-400.
15. Hatzis P and Talianidis I. (2001). Mol. Cell. Biol., 21, 7320-7330.
16. Jayasuriya H, Lingham RB, Graham P, Quamina D, Herranz L, Genilloud O, Gagliardi M, Danzeisen R, Tomassini JE, Zink DL, Guan ZQ and Singh SB. (2002). J. Nat. Prod., 65, 1091-1095.
17. Kardassis D, Falvey E, Tsantili P, Hadzopoulou-Cladaras M and Zannis VI. (2002). Biochemistry, 41, 1217-1228.
18. Kardassis D, Pardali K and Zannis VI. (2000). J. Biol. Chem., 275, 41405-41414.
19. Kardassis D, Zannis VI and Cladaras C. (1992). J Biol Chem., 267, 2622-2632.
20. Kohn KW. (1999). Mol. Biol. Cell, 10, 2703-2734.
21. Koutsodontis G, Moustakas A and Kardassis D. (2002). Biochemistry, 41, 12771-12784.
22. Koutsodontis G, Tentes I, Papakosta P, Moustakas A and Kardassis D. (2001). J. Biol. Chem., 276, 29116-29125.
23. Kuo MH and Allis CD. (1999). Methods, 19, 425-433.
24. Ladias JA, Hadzopoulou-Cladaras M, Kardassis D, Cardot P, Cheng J, Zannis VI and Cladaras C. (1992). J. Biol. Chem., 267, 15849-15860.
25. Lehman TA, Modali R, Boukamp P, Stanek J, Bennett WP, Welsh JA, Metcalf RA, Stampfer MR, Fusenig N and Rogan EM. (1993). Carcinogenesis, 14, 833-839.
26. Levine AJ. (1997). Cell, 88, 323-331.
27. Longley DB, Harkin DP and Johnston PG. (2003). Nat. Rev. Cancer., 3, 330-338.
28. Majee S and Chakrabarti A. (1999). Biochem. Pharmacol., 57, 981-987.
29. Majee S, Dasgupta D and Chakrabarti A. (1999). Eur. J. Biochem., 260, 619-626.
30. Miller DM, Polansky DA, Thomas DD, Ray R, Campbell VW, Sanchez J and Koller CA. (1987). Am. J. Med. Sci., 294, 388-394.
31. Moustakas A and Kardassis D. (1998). Proc. Natl. Acad. Sci. USA, 95, 6733-6738.
32. Nehls MC, Brenner DA, Gruss HJ, Dierbach H, Mertelsmann R and Herrmann F. (1993). J. Clin. Invest., 92, 2916-2921.
33. Orlando V. (2000). Trends Biochem. Sci., 25, 99-104.
34. Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D and Moustakas A. (2000). J. Biol. Chem., 275, 29244-29256.
35. Ray R, Snyder RC, Thomas S, Koller CA and Miller DM. (1989). J. Clin. Invest., 83, 2003-2007.
36. Remsing LL, Bahadori HR, Carbone GM, McGuffie EM, Catapano CV and Rohr J. (2003). Biochemistry, 42, 8313-8324.
37. Ryan WG, Schwartz TB and Northrop G. (1970). J. Am. Med. Assoc., 213, 1153-1157.
38. Schavinsky-Khrapunsky Y, Huleihel M, Aboud M and Torgeman A. (2003). Oncogene, 22, 5315-5324.
39. Schneider I. (1972). J. Embryol. Exp. Morphol., 27, 353-365.
40. Seoane J, Le HV and Massague J. (2002). Nature, 419, 729-734.
41. Snyder RC, Ray R, Blume S and Miller DM. (1991). Biochemistry, 30, 4290-4297.
42. Strano S, Fontemaggi G, Costanzo A, Rizzo MG, Monti O, Baccarini A, Del Sal G, Levrero M, Sacchi A, Oren M and Blandino G. (2002). J. Biol. Chem., 277, 18817-18826.
43. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.
44. Yu J, Wang Z, Kinzler KW, Vogelstein B and Zhang L. (2003). Proc. Natl. Acad. Sci. USA, 100, 1931-1936.
45. Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B. (2001). Mol. Cell, 7, 673-682.
46. Zhang H, Hannon GJ, Casso D and Beach D. (1994). Cold Spring Harb. Symp. Quant. Biol., 59, 21-29.
47. Zhang H, Xiong Y and Beach D. (1993). Mol. Biol. Cell, 4, 897-906.